The BRCA genes were first described in families with breast and ovarian cancers through genetic linkage analysis.1–3 A meta-analysis of 10 studies estimated the lifetime risk of breast cancer in BRCA1 carriers to be ~47–66 and 40–57% in BRCA2 carriers. This evidence concerns the gene BRCA2 and breast cancer.